Financial statements Biosciences Mt
Balance sheet data of BIOSCIENCES MT
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 425 756,62 | 1 337 149,05 | 1 361 758,34 | 1 384 695,32 | 1 211 217,62 | 1 731 420,08 |
| A. Fixed assets | 710 109,38 | 482 184,00 | 482 258,16 | 477 308,16 | 472 358,16 | 467 408,16 |
| B. Current assets | 715 647,24 | 854 965,05 | 879 500,18 | 907 387,16 | 738 859,46 | 1 264 011,92 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 1 425 756,62 | 1 337 149,05 | 1 361 758,34 | 1 384 695,32 | 1 211 217,62 | 1 731 420,08 |
| A. Equity | 1 324 846,94 | 1 256 920,28 | 1 285 898,59 | 1 331 939,62 | 1 197 571,55 | 1 703 090,33 |
| B. Liabilities and provisions for liabilities | 100 909,68 | 80 228,77 | 75 859,75 | 52 755,70 | 13 646,07 | 28 329,75 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 100 909,68 | 80 228,77 | 75 859,75 | 52 755,70 | 13 646,07 | 28 329,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.